EMBO Announces 52 New Members for 2013
News May 21, 2013
Forty-three of the researchers reside in Europe and neighboring countries and are accompanied by the election of nine Associate Members from Canada, China, India, Japan and the United States. The EMBO membership currently comprises around 1600 life scientists.
“Our members are the basis for the international reputation of our organisation,” EMBO Director Maria Leptin said. “We have been building our network of members for almost 50 years and the EMBO membership is the foundation for our future growth and achievements. I look forward to the fresh input and ideas that the new EMBO members will bring to the organisation.”
The most recent scientists to join the EMBO membership come from 15 different countries and include 16 female scientists.
EMBO Members make invaluable contributions to the organization by providing suggestions and feedback on the activities of EMBO. They serve on selection committees for EMBO programmes and mentor young scientists. Their input has helped to promote excellence in life sciences since 1964.
Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult LymphomaNews
Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.READ MORE